Evidence map›Paper›PMID 22686564›Full record

ReviewSeminars in dialysis2012

The controversies of diagnosing and treating hypertension among hemodialysis patients.

Rajiv Agarwal

Abstract readReview
In one paragraph

Review in Seminars in dialysis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Evidence-based cardiology in hemodialysis patients.Journal of the American Society of Nephrology : JASN · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Rajiv AgarwalIndiana University School of Medicine and Roudebush VA Medical Center, Indianapolis, Indiana 46202, USA. ragarwal@iupui.edu

Funding

Hypertension in Hemodialysis PatientsR01DK062030 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI AGARWAL, RAJIV · 2003 to 2013
$3.8M
NIDDK NIH HHS 2R01-DK062030-08NIDDK NIH HHS R01 DK062030
6 · The paper itself

Abstract

This review discusses 10 current controversies regarding the dialysis patient with hypertension. The clinician is faced with a dilemma at the bedside on how to evaluate blood pressure and treat this condition in a patient on long-term hemodialysis. The evidence base to give firm recommendations is thin, but the epidemiological evidence tells us to do nothing. This appears to be an incorrect strategy, at least based on what we know today. Evaluating home BP in every dialysis patient, evaluating volume status on a regular basis, and treating hypertension predominantly with nonpharmacological strategies are worthwhile.

Indexed as

Renal DialysisAntihypertensive AgentsBlood PressureBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryDiet, Sodium-RestrictedExtracellular FluidHemofiltrationHumansHypertensionKidney Failure, ChronicPlasma VolumePrognosisAntihypertensive Agents

Identifiers

PMID22686564
PMCPMC3400711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.